Table 2 Correlations between performance on each expression recognition task and participant characteristics, symptom severity, and level of adaptive behaviour, by group (N in brackets)
From: Facial expression recognition is linked to clinical and neurofunctional differences in autism
| Â | Autism | Control | ||||
|---|---|---|---|---|---|---|
KDEF | RMET | FET | KDEF | RMET | FET | |
VIQ | 0.36**** (249) | 0.48***** (270) | 0.50**** (146) | 0.24*** (150) | 0.21** (210) | 0.44**** (107) |
PIQ | 0.34**** (250) | 0.42**** (272) | 0.47***** (147) | 0.0.38**** (150) | 0.25*** (210) | 0.27** (107) |
FSIQ | 0.37**** (249) | 0.50***** (270) | 0.53**** (146) | 0.32*** (150) | 0.24*** (210) | 0.39*** (107) |
Age | 0.15* (261) |  − 0.03 (276) | 0.11 (148) | 0.11 (150) |  − 0.03 (210) |  − 00.1 (107) |
SRS-2, |  − 0.19** (214) |  − 0.22** (239) |  − 0.33**** (126) |  − 0.20 (87) |  − 0.15 (117) |  − 0.49*** (63) |
ADOS, CSS |  − 0.30**** (186) |  − 0.39***** (204) |  − 0.51***** (105) | – | – | – |
RBS-R |  − 0.19 (212) |  − 0.10 (232) |  − 0.28*** (123) |  − 0.25 (88) |  − 0.12 (114) |  − 40** (64) |
VABS-2 | 0.21** (215) | 0.22** (230) | 0.36**** (126) | 0.64** (16) | 0.56** (15) | 0.57* (13) |
Neuropsychiatric symptoms |  − 0.12 (251) | 0.02 (276) |  − 0.08 (148) |  − 0.13 (150) |  − 0.18* (211) |  − 0.31** (107) |
Medication use | 0.11 (238) |  − 0.01 (264) | 0.05 (146) |  − 0.15 (132) |  − 0.04 (198) |  − 0.15 (99) |